DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epivir (Lamivudine) - Adverse Event Reports - All Cases - Immune Reconstitution Syndrome

 



Index of reports > All cases (204) > Cases with Immune Reconstitution Syndrome (13)

Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes all cases where reactions include immune reconstitution syndrome.

Adverse event in 36 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-07-23

Patient: 36 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Body Temperature Increased, Pleuritic Pain, Wheezing, Kaposi's Sarcoma, Pyrexia, Chest X-RAY Abnormal, Mycobacterium Avium Complex Infection, Acid Fast Bacilli Infection, Acute Respiratory Distress Syndrome, Crepitations, Sputum Culture Positive, Cough, Respiratory Rate Increased, Dyspnoea, Necrotising Granulomatous Lymphadenitis, Granuloma, Computerised Tomogram Abnormal, Human Herpesvirus 8 Infection, Bronchoalveolar Lavage Abnormal, Respiratory Failure, Inflammation

Adverse event resulted in: death

Suspect drug(s):
Epivir
    Indication: Kaposi's Sarcoma

Tenofovir Disoproxil Fumarate
    Indication: Kaposi's Sarcoma

Ritonavir (Formulation Unknown) (Ritonavir)
    Indication: Kaposi's Sarcoma

Atazanavir (Formulation Unknown) (Atazanavir)
    Indication: Kaposi's Sarcoma

Stealth Lip.doxorubicin (Formulation Unknown) (Stealth Lip.doxorubicin
    Indication: Kaposi's Sarcoma



Adverse event in 33 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-06-05

Patient: 33 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Rhinitis Allergic, Iron Deficiency Anaemia, Cytomegalovirus Viraemia, Upper Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Valixa
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2005-06-13

Valixa
    Dosage: indication: cytomegalovirus viraemia. drug maintained as of 31 march 2006.
    Administration route: Oral
    Start date: 2005-09-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Epivir
    Administration route: Oral
    Start date: 2005-08-03

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Zerit
    Administration route: Oral
    Start date: 2005-08-03

Other drugs received by patient: Stocrin; Diflucan; Truvada; Ketotifen



Adverse event in 33 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-04-16

Patient: 33 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Rhinitis Allergic, Iron Deficiency Anaemia, Cytomegalovirus Viraemia, Upper Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Valixa
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2005-06-13

Valixa
    Administration route: Oral
    Start date: 2005-09-21

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Epivir
    Administration route: Oral
    Start date: 2005-08-03

Zerit
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2005-05-18

Zerit
    Start date: 2005-08-03

Other drugs received by patient: Stocrin; Diflucan; Truvada



Adverse event in 51 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from France on 2007-03-26

Patient: 51 year old male

Adverse reactions / side effects: Lymphadenopathy, Immune Reconstitution Syndrome, Hepatic Function Abnormal, Cholestasis, Erythema, Drug Toxicity, Skin Lesion, Bone Disorder, Leukocyturia, Sarcoidosis, Splenomegaly, Granulomatous Liver Disease, Renal Failure Acute, Renal Tuberculosis, Haematuria, Disseminated Tuberculosis, Drug Intolerance, Eosinophil Count Increased, Granuloma, Nephritis Interstitial

Suspect drug(s):
Retrovir
    Indication: HIV Infection

Epivir
    Indication: HIV Infection

Lexiva
    Indication: HIV Infection

Ritonavir (Formulation Unknown) (Ritonavir)
    Indication: HIV Infection

Moxifloxacin HCL

Other drugs received by patient: CO-Trimoxazole



Adverse event in 37 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-03-21

Patient: 37 year old male

Adverse reactions / side effects: Back Pain, Immune Reconstitution Syndrome, Pain in Extremity, Rash, Disorientation, Cerebral Toxoplasmosis, Herpes Zoster, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2006-03-23

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29

Denosine (Ganciclovir)
    Dosage: 5mgk twice per day
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-03-11
    End date: 2005-04-24

Valixa
    Dosage: 900mg twice per day
    Administration route: Oral
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-04-25
    End date: 2005-07-21

Baktar
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    Start date: 2005-03-12
    End date: 2005-04-06

Lectisol
    Dosage: 50mg per day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    Start date: 2005-06-23
    End date: 2005-06-28

Other drugs received by patient: Ziagen; Zithromac; Pentamidine Isethionate; Cortril; Diflucan; Fungizone



Adverse event in 41 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-03-20

Patient: 41 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased

Suspect drug(s):
Epivir
    Indication: HIV Infection

Tenofovir (Formulation Unknown) (Tenofovir)
    Indication: HIV Infection

Retrovir
    Indication: HIV Infection

Nelfinavir Mesylate (Formulation Unknown) (Nelfinavir Mesylate)
    Indication: HIV Infection

Other drugs received by patient: CO-Trimoxazole; Azithromycin



Adverse event in 47 year old female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-03-20

Patient: 47 year old female

Adverse reactions / side effects: Immune Reconstitution Syndrome, Anti-HBC IGM Antibody Positive, Hepatotoxicity, Condition Aggravated, Gallbladder Disorder, Hepatitis, Hepatitis B Surface Antigen Positive

Suspect drug(s):
Epivir

Tenofovir (Formulation Unknown) (Tenofovir)

Lopinavir + Ritonavir (Formulation Unknown) (Lopinavir + Ritonavir)

Other drugs received by patient: CO-Trimoxazole; Azithromycin



Adverse event in 42 year old female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United States on 2007-03-20

Patient: 42 year old female

Adverse reactions / side effects: Drug Toxicity, Immune Reconstitution Syndrome, Condition Aggravated, Hepatitis B

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Indication: HIV Infection

Tenofovir (Formulation Unknown)
    Indication: HIV Infection

Nelfinavir Mesylate (Formulation Unknown) (Nelfinavir Mesylate)

Other drugs received by patient: Dapsone; Azithromycin; Ethambutol Hydrochloride



Adverse event in 31 year old male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from United Kingdom on 2007-03-07

Patient: 31 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Kaposi's Sarcoma, Colonic Polyp, Neoplasm Recurrence, Diarrhoea Haemorrhagic, Colon Adenoma, Pleural Effusion, Schistosomiasis

Suspect drug(s):
Epivir
    Indication: HIV Infection
    Start date: 2003-11-01

Tenofovir (Formulation Unknown) (Tenofovir)
    Indication: HIV Infection

Efavirenz
    Indication: HIV Infection

Other drugs received by patient: Fluconazole; CO-Trimoxazole; Doxorubicin HCL



Adverse event in female receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from South Africa on 2007-02-12

Patient: female

Adverse reactions / side effects: Immune Reconstitution Syndrome, Kidney Transplant Rejection

Suspect drug(s):
Epivir
    Indication: HIV Infection

Stavudine
    Indication: HIV Infection

Efavirenz
    Indication: HIV Infection

Other drugs received by patient: Immunosuppressive



Adverse event in 38 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-02-08

Patient: 38 year old male

Adverse reactions / side effects: Immune Reconstitution Syndrome, Kaposi's Sarcoma

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Other drugs received by patient: Pyrimethamine TAB; Sulfadiazine; Sulfamethoxazole



Adverse event in 37 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-02-01

Patient: 37 year old male

Adverse reactions / side effects: Back Pain, Immune Reconstitution Syndrome, Pain in Extremity, Disorientation, Rash, Cerebral Toxoplasmosis, Herpes Zoster, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29
    End date: 2006-03-23

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-03-29

Denosine (Adenosine Triphosphate)
    Dosage: 5mgk twice per day
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-03-11
    End date: 2005-04-24

Valixa
    Dosage: 900mg twice per day
    Administration route: Oral
    Indication: Cytomegalovirus Enterocolitis
    Start date: 2005-04-25
    End date: 2005-07-21

Bactrim
    Dosage: 1 per day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    Start date: 2005-03-12
    End date: 2005-04-06

Other drugs received by patient: Ziagen; Zithromac; Pentamidine Isethionate; Lectisol; Cortril; Diflucan; Fungizone



Adverse event in 29 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-02-01

Patient: 29 year old female

Adverse reactions / side effects: Abdominal Pain, Immune Reconstitution Syndrome, Tuberculosis Gastrointestinal

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-07-22
    End date: 2005-08-09

Epzicom
    Dosage: 1tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-18

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-07-22
    End date: 2005-08-09

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-18

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-07-22
    End date: 2005-08-09

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-11-18

Other drugs received by patient: Clarithromycin; Zithromac; Bactrim; Benambax; Ciprofloxacin; Rifabutin; Pydoxal

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009